Culture Biosciences Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
80
- Latest Deal Type
-
Series C
- Investors
-
26
Culture Biosciences General Information
Description
Developer of automated bioreactors and software designed to help companies optimize their manufacturing processes. The company designs, monitors, and analyzes bioreactors for sensitive cell cultures and high cell density fermentation, enabling biotech companies to optimize manufacturing processes and simulate performance at scale.
Contact Information
Website
www.culturebiosciences.comCorporate Office
- 269 East Grand Avenue
- South San Francisco, CA 94080
- United States
Corporate Office
- 269 East Grand Avenue
- South San Francisco, CA 94080
- United States
Culture Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series C) | 16-Dec-2025 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series B) | 10-Sep-2021 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 03-May-2020 | Completed | Generating Revenue | |||
| 7. Early Stage VC (Series A) | 04-Mar-2020 | Completed | Generating Revenue | |||
| 6. Grant | 15-Sep-2019 | Completed | Generating Revenue | |||
| 5. Seed Round | 12-Feb-2019 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 19-Mar-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2017 | Completed | Startup | |||
| 2. Grant | 01-Jan-2017 | $225K | Completed | Startup | ||
| 1. University Spin-Out | 01-Oct-2016 | Completed | Startup |
Culture Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-6 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 910,194 | $0.000010 | $0.33 | $0.33 | 1x | $0.33 | 2.29% | |
| Series A-1 | 9,258,333 | $0.000010 | $1.63 | $1.63 | 1x | $1.63 | 23.33% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Culture Biosciences Comparisons
Industry
Financing
Details
Culture Biosciences Competitors (7)
One of Culture Biosciences’s 7 competitors is Paradigm4, a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Paradigm4 | Venture Capital-Backed | Waltham, MA | ||||
| Solaris Biotech by Donaldson USA | Corporation | Berkeley, CA | ||||
| PBS Biotech | Private Equity-Backed | Camarillo, CA | ||||
| Eppendorf | Corporation | Hamburg, Germany | ||||
| Solaris Biotechnology | Corporate Backed or Acquired | Mantova, Italy |
Culture Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Culture Biosciences Patents
Culture Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-2642939-A | Vessel components for use in small scale bioreactors | Active | 25-Apr-2024 | ||
| GB-2642939-B | Vessel components for use in small scale bioreactors | Active | 25-Apr-2024 | ||
| US-20250333675-A1 | Vessel components for use in small scale bioreactors | Pending | 25-Apr-2024 | ||
| US-20260117157-A1 | Vessel components for use in small scale bioreactors | Pending | 25-Apr-2024 | ||
| WO-2025227123-A1 | Vessel components for use in small scale bioreactors | Pending | 25-Apr-2024 | C12M41/22 |
Culture Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Culture Biosciences Investors (26)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fundamental Ventures | Venture Capital | Minority | ||
| GRIDS Capital | Venture Capital | Minority | ||
| Happiness Capital | Corporate Venture Capital | Minority | ||
| Northpond Ventures | Venture Capital | Minority | ||
| Synthesis Capital | Venture Capital | Minority |
Culture Biosciences FAQs
-
When was Culture Biosciences founded?
Culture Biosciences was founded in 2016.
-
Where is Culture Biosciences headquartered?
Culture Biosciences is headquartered in South San Francisco, CA.
-
What is the size of Culture Biosciences?
Culture Biosciences has 80 total employees.
-
What industry is Culture Biosciences in?
Culture Biosciences’s primary industry is Discovery Tools (Healthcare).
-
Is Culture Biosciences a private or public company?
Culture Biosciences is a Private company.
-
What is Culture Biosciences’s current revenue?
The current revenue for Culture Biosciences is .
-
How much funding has Culture Biosciences raised over time?
Culture Biosciences has raised $107M.
-
Who are Culture Biosciences’s investors?
Fundamental Ventures, GRIDS Capital, Happiness Capital, Northpond Ventures, and Synthesis Capital are 5 of 26 investors who have invested in Culture Biosciences.
-
Who are Culture Biosciences’s competitors?
Paradigm4, Solaris Biotech by Donaldson USA, PBS Biotech, Eppendorf, and Solaris Biotechnology are some of the 7 competitors of Culture Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
